Selective use of the muscarinic receptor blockader gastrozepine in preventing Mendelson's syndrome in obstetrics
Nowak, J.
Ginekologia Polska 57(12): 797-800
1986
ISSN/ISBN: 0017-0011 PMID: 3570027 Document Number: 273569
Document emailed within 1 workday
Related Documents
Criado Jiménez, A.; Alvarez Escudero, J.; Cordon Mazo, J.; Cortes Laiño, J.; Avello García, F. 1981: Cimetidine premedication for preventing Mendelson syndrome under anesthesia Revista Espanola de Anestesiologia y Reanimacion 28(6): 303-305Vokrouhlická, J.; Pavo, I.; Stĕpán, J. 1998: Selective estrogen receptor modulators as a new concept in preventing health risks of menopause Casopis Lekaru Ceskych 137(22): 679-685
Trevisan, P. 1999: Succinylcholine and Mendelson's syndrome Minerva Anestesiologica 65(10): 753-755
Siegel, J.N.; June, C.H.; Yamada, H.; Rapp, U.R.; Samelson, L.E. 1993: Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells Journal of Immunology 151(8): 4116-4127
Seigne, T.D. 1971: A successfully treated case of Mendelson's syndrome Journal of the Irish Medical Association 64(406): 109-112
Yang, J.; Logsdon, C.D.; Johansen, T.E.; Williams, J.A. 1993: Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation Molecular Pharmacology 44(6): 1158-1164
Prieto, P.; Tello, I.; Barbero, L.; Cuenca, J.; Rull, M.; Bertrán, N. 1993: Omeprazole in the prophylaxis of Mendelson syndrome in elective surgery Revista Espanola de Anestesiologia y Reanimacion 40(3): 129-131
Bifarini, G.; Trabalza, N.; Falconi, S.; Malà, L.; Favetta, P. 1990: Possible effects of pharmacologic prophylaxis for Mendelson's syndrome on newborns Minerva Anestesiologica 56(12): 1447-1450
Schmidt, E.; Bruch H-P 1978: 1st experiences with the alpha-receptor blockader phentolamine in achalasia Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 49(1): 22-24
Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Qvist, N.; Storm, K. 1983: Cimethidine pre-anesthetic. A prophylactic method against Mendelson's syndrome in cesarean section Acta Obstetricia et Gynecologica Scandinavica 62(2): 157-159
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Gränzer, W.; Eichinger, H. 1982: Inhibition of isoprenaline-induced tachycardia in calves with the beta-receptor blockader carazolol Berliner und Munchener Tierarztliche Wochenschrift 95(3): 47-49
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Kwatra, M.M.; Ptasienski, J.; Hosey, M.M. 1989: The porcine heart M2 muscarinic receptor: agonist-induced phosphorylation and comparison of properties with the chick heart receptor Molecular Pharmacology 35(5): 553-558
Marti, J.J.; Ammann, C.; de Gasparo, D. 1979: Preoperative administration of antacids to prevent Mendelson's syndrome in pregnant women receiving general anesthesia Geburtshilfe und Frauenheilkunde 39(12): 1069-1078
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061